Searched for
LUPIN REVENUE GROWTH
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...12 Jun, 2026, 12.25 PM IST- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...11 Jun, 2026, 10.31 AM IST
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...04 May, 2026, 06.00 AM IST
- Lupin shares jump 2% as Q2 PAT soars 73% YoY to Rs 1,485 croreLupin shares rose on Friday after the pharma major reported a robust 73% YoY surge in Q2 FY26 PAT to Rs 1,485 crore, driven by strong sales...07 Nov, 2025, 11.56 AM IST
- Drug companies set for improved revenue growth in June quarter amid US market challengesIndian pharma and healthcare companies anticipate improved revenue and profit in the June 2025 quarter, fueled by domestic market growth. H...22 Jul, 2025, 06.12 AM IST
- CDMO sector to be key beneficiary of China+1 strategy in pharma: Vishal ManchandaSystematix Group's Vishal Manchanda anticipates Q4 results for pharma companies to align with previous quarters, with high single-digit dom...23 Apr, 2025, 12.14 PM IST
- Lupin shares drop 3% after Q3 resultsShares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged 102.7%, reach...12 Feb, 2025, 11.06 AM IST
- US show a plus for Cipla, Lupin confident of recoveryThe domestic business grew 6 per cent, showing the impact of a high base effect.13 Feb, 2019, 12.05 PM IST
- Add Lupin Ltd. target Rs 815: ICICI DirectAdd Lupin Ltd. at a price target of Rs 815.17 May, 2018, 10.18 AM IST
- Stock pick of the week: Why analysts are bullish on LupinIn addition to growth in sales in respective markets, favourable currency movement has also helped Lupin to achieve high growth.17 Mar, 2017, 04.59 PM IST
- Rising local sales, strong drug pipeline may nurse Lupin back to healthAfter a stellar show in earlier years, where it grew an average 20 per cent annually , it has been difficult for Lupin to sustain growth.24 Jul, 2015, 10.22 AM IST
- US Generic launches are key to Lupin growthLupin's revenue grew 5% yearon-year to Rs 3,144.9 crore during the December 2014 quarter, much lower than the analysts' expectation of 12-1...04 Feb, 2015, 12.29 PM IST
- Looking to acquire companies and launch new products in India: LupinHomegrown drug major Lupin is looking to acquire companies and launch new products in the domestic market as it aims to scale up its Indian...14 Dec, 2014, 02.24 PM IST
- Lupin Pharma's India business a cause for concernLupin Pharma’s underperformance in the domestic market may rein in investors’ bullish stance on the share — a hitherto darling of the India...08 May, 2014, 04.25 AM IST
- Lupin to file new drug application for GSK’s $8 bn blockbuster inhaler AdvairMumbai-based drug maker Lupin Pharma will file an Abbreviated New Drug Application for GSK’s $8-billion dry powder inhaler Advair, said Vin...26 Jul, 2012, 11.49 AM IST
- Local manufacturing can boost margins for LupinFor a fairly consistent performer in terms of top line growth in the pharma industry, drug maker Lupin’s show in the quarter to December wa...26 Jan, 2012, 02.45 AM IST
- Lupin scouts for buys in Latin AmericaThe company expects to launch 10 new products in Japan this year, considered the most difficult of three developed pharmaceutical markets -...06 Jan, 2011, 05.06 AM IST
Load More
